Package 49502-450-93

{"route": ["ORAL"], "spl_id": "e63f53ae-04f8-4bbc-afa1-c62078f09855", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95", "OTT9J7900I"], "rxcui": ["2003249", "2003255"], "spl_set_id": ["a300f04d-118f-4136-aaf3-ddfd00197f86"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Viatris Specialty LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (49502-450-93)  / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "49502-450-93", "marketing_start_date": "20180625"}], "brand_name": "CIMDUO", "product_id": "49502-450_e63f53ae-04f8-4bbc-afa1-c62078f09855", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "49502-450", "generic_name": "Lamivudine and Tenofovir Disoproxil Fumarate", "labeler_name": "Viatris Specialty LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CIMDUO", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "300 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "NDA022141", "marketing_category": "NDA", "marketing_start_date": "20180625", "listing_expiration_date": "20261231"}